Company News

  November 17, 2025 Global Tour 2025 · Key Station for European Market Penetration   From November 17 to 20, the world-renowned MEDICA 2025 kicked off grandly in Düsseldorf, Germany. As the "barometer" of the global medical industry, this exhibition gathered over 6,000 exhibi...

On September 20, at the 27th Annual Congress of the Chinese Society of Cardiology, the 23rd Interventional Cardiology Congress, and the 2025 Chang’an Cardiology Congress, the "Symposium on the Application of Artificial Intelligence-OCT (AI-OCT) in PCI Precision Diagnosis and Treatment" was gra...

San Francisco, October 2025 — Transcatheter Cardiovascular Therapeutics (TCT) is one of the world’s leading conferences dedicated to interventional cardiology. The 37th edition of TCT will take place at the Moscone Convention Center in San Francisco from October 25 to 28, 2025. Brin...

Dr. Ning Guo Demonstrates the Power of Integrating Morphology and Physiology Assessment for Precise PCI   Hong Kong, October 4, 2025 – The Innovative Cardiovascular Initiative Summit 2025 (ICI 2025) commenced today at the Hong Kong Science Park, gathering leading experts in interventional...

Madrid, Spain – September 1, 2025 – At the European Society of Cardiology (ESC) Congress 2025 in Madrid, the Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) reported landmark clinical results on an optical coherence tomography–based functional assessmen...

A Remarkable Win at the 8th Secret Light Awards   On June 4, 2025, Vivolight Medical won the Cutting-Edge Innovation Award at the 8th Secret Light Awards (SLA) held at Hilton Shenzhen World Exhibition & Convention Center. Its 355 nm cold-laser plaque-ablation system was chosen from among 20...

EuroPCR 2025 concluded with a wave of technological breakthroughs, and Vivolight Medical stood at the forefront with its revolutionary P80 Multimodal Cardiovascular OCT System. As the world’s first FDA-cleared OCT platform featuring integrated AI diagnosis, the P80 attracted global i...

April 11, 2025, Vivolight Medical announced that its independently developed Optical Coherence Tomography (OCT) system has obtained FDA 510(k) clearance. This milestone not only enbale the U.S. market entry, but also streamlines regulatory pathways across 20+ countries recog...

Optical Coherence Tomography (OCT) is revolutionizing modern cardiovascular interventions by providing high-resolution imaging for precise diagnosis and treatment. Recently, RSUD Al-Ihsan Hospital in Bandung, Indonesia, successfully performed two complex coronary interventions utilizing Vivolight OC...

Vivolight Medical’s at Arab Health 2025: Illuminating a New Era of Global Cooperation in the Year of the Snake   From January 27 to January 30, 2025, Vivolight Medical made a dazzling appearance at the global medical technology event—Arab Health 2025, showcasing China&rsqu...

Azerbaijan recently completed its First PCI Case Guided by Vivolight’s Multimodal P80 OCT (Optical Coherence Tomography) system, marking a groundbreaking achievement in the region’s cardiovascular care. Led by Dr. Ulvi, a renowned cardiologist, this milestone highlights Vi...

The LX Congreso Chileno de Cardiología y Cirugía Cardiovascular represents a distinguished academic forum, convening preeminent physicians from across the globe. This esteemed conference serves as a pivotal platform for the dissemination of the latest advancements in cardiology, a...